XML 35 R8.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED AND CONDENSED STATEMENTS OF CASH FLOWS (Unaudited) (USD $)
9 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Cash flows from operating activities:    
Net Income $ 90,122,000 $ 21,491,000
Less: Income from discontinued operations (67,312,000) (7,728,000)
Net income from continuing operations 22,810,000 13,763,000
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 29,457,000 29,523,000
Amortization of deferred debt issuance costs 2,611,000 3,071,000
Amortization of debt discount 504,000 262,000
Loss on sale of property, plant and equipment 7,000 405,000
Gain on sale of equity method investment (486,000) 0
Equity in earnings (loss) of unconsolidated entities 532,000 (100,000)
Other 379,000 131,000
Change in current assets and liabilities, excluding effects of acquisitions and dispositions:    
Accounts and other receivables (6,328,000) (4,788,000)
Product exchange receivables 12,190,000 (16,552,000)
Inventories (38,583,000) (28,057,000)
Due from affiliates (27,795,000) 221,000
Other current assets 431,000 1,874,000
Trade and other accounts payable (8,533,000) 11,733,000
Product exchange payables (9,405,000) 27,350,000
Due to affiliates 4,469,000 3,430,000
Income taxes payable (96,000) (799,000)
Other accrued liabilities 840,000 4,218,000
Change in other non-current assets and liabilities (1,126,000) (123,000)
Net cash provided by (used in) continuing operating activities (18,122,000) 45,562,000
Net cash provided by discontinued operating activities 120,000 12,272,000
Net cash provided by (used in) operating activities (18,002,000) 57,834,000
Cash flows from investing activities:    
Payments for property, plant, and equipment (63,009,000) (48,769,000)
Acquisitions 0 (16,815,000)
Payments for plant turnaround costs (2,578,000) (2,103,000)
Proceeds from sale of property, plant, and equipment 33,000 530,000
Proceeds from sale of equity method investment 531,000 0
Investment in unconsolidated subsidiaries (775,000) (59,319,000)
Return of investments from unconsolidated entities 5,133,000 383,000
Distributions from (contributions to) unconsolidated entities for operations (22,786,000) (929,000)
Net cash used in continuing investing activities (83,451,000) (127,022,000)
Net cash provided by (used in) discontinued investing activities 271,181,000 (8,253,000)
Net cash provided by (used in) investing activities 187,730,000 (135,275,000)
Cash flows from financing activities:    
Payments of long-term debt (547,000,000) (389,000,000)
Payments of notes payable and capital lease obligations (6,522,000) (831,000)
Proceeds from long-term debt 349,000,000 456,000,000
Net proceeds from follow on offering 91,361,000 70,330,000
General partner contribution 1,951,000 1,505,000
Treasury units purchased (221,000) (582,000)
Payment of debt issuance costs (204,000) (3,424,000)
Excess purchase price over carrying value of acquired assets 0 (19,685,000)
Cash distributions paid (58,332,000) (47,956,000)
Net cash provided by (used in) financing activities (169,967,000) 66,357,000
Net decrease in cash (239,000) (11,084,000)
Cash at beginning of period 266,000 11,380,000
Cash at end of period $ 27,000 $ 296,000